Singapore markets closed

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

SES - SES Delayed price. Currency in USD
Add to watchlist
1.9700-0.0200 (-1.01%)
At close: 04:57PM SGT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
7,118,333
8,222,312
8,249,250
6,907,544
6,603,652
Cost of revenue
4,330,775
4,604,083
4,955,592
4,150,424
4,027,755
Gross profit
2,787,558
3,618,228
3,293,658
2,757,120
2,575,897
Operating expenses
Research development
158,846
184,629
153,147
161,052
149,202
Selling general and administrative
1,637,620
2,184,549
2,049,442
1,645,040
1,541,679
Total operating expenses
2,138,873
2,749,975
2,570,316
2,143,941
1,979,962
Operating income or loss
648,685
868,253
723,342
613,179
595,934
Interest expense
3,833
35,853
10,269
2,937
6.66
Income before tax
956,810
1,095,364
980,188
872,806
768,058
Income tax expense
100,725
126,658
106,931
85,929
88,396
Income from continuing operations
856,086
968,706
873,258
786,877
679,662
Net income
836,594
986,707
861,794
769,144
661,704
Net income available to common shareholders
836,594
986,707
861,794
769,144
661,704
Basic EPS
1.28
1.28
1.12
1.00
0.86
Diluted EPS
1.28
1.28
1.11
1.00
0.86
Basic average shares
773,823
770,865
769,459
769,144
769,424
Diluted average shares
774,633
770,865
776,391
769,144
769,424